Susan G. Komen for the Cure
5005 LBJ Freeway
49 articles with Susan G. Komen for the Cure
Cubii Announces Donation of 500 Ellipticals to Support Breast Cancer Patients and Survivors in Illinois
Donations will be made across the state in partnership with Susan G. Komen Chicago and the University of Chicago Cancer Research Foundation
33 Organizations Representing Millions of Patients Urge Policymakers to Adopt "Patient-First" Policy Agenda
A coalition of 33 organizations representing millions of people with pre-existing conditions launched an unprecedented effort by releasing their top priorities for the next Administration.
Susan G. Komen®, the world’s leading breast cancer organization, welcomed the results of the INFORM trial that were announced at the 2019 San Antonio Breast Cancer Symposium.
Walgreens, Susan G. Komen and The Leukemia & Lymphoma Society Collaborate to Support Research in Tough-to-Treat Cancers and Increase Access to Care
$25M, multi-year commitment builds on Walgreens efforts to improve the health and well-being of people living with cancer nationwide
Komen vows to drive breakthroughs for the most-deadly breast cancers and educate those who believe breast cancers are easily treated or always curable
Susan G. Komen® Welcomes Leaders in Finance, Pharma, Marketing and Philanthropy to Board of Directors
Susan G. Komen®, the world’s leading breast cancer organization, welcomed five new members to its Board of Directors.
Susan G. Komen® Announces New Funding Opportunity Focused on Better Understanding of Breast Cancer Disparities
Made possible by a grant from Genentech, a Member of the Roche Group, the organization invited Komen-funded researchers to apply for supplemental funding to expand existing research projects by adding a disparity lens, with the goal of better understanding and addressing disparities in breast cancer outcomes.
Collaboration Focused on Newly Announced “Know Your Girls™” Campaign
Susan G. Komen® Hails Findings from KATHERINE Trial Showing New Treatment Option That Reduces Breast Cancer Recurrence/Death Risk
Findings provide hope for long-term survival for HER2+ breast cancer patients
Susan G. Komen® Announces $26 Million Investment in New Research to Find Solutions for Aggressive and Metastatic Breast Cancers, and to Help Communities Most at Risk
Susan G. Komen® today announced an additional investment of nearly $26 million to fund 62 new research projects that seek to answer some of the toughest questions facing breast cancer.
Susan G. Komen Statement on TAILORx Study Citing Chemotherapy Not Needed for Some Breast Cancer Patients
Susan G. Komen® issued the following statement today regarding a new study partially funded by the organization – called Trial Assigning Individualized Options for Treatment, or TAILORx.
Susan G. Komen for the Cure Joins Forces With Heron To Raise Awareness Of The Supportive Care Needs Of Patients With Breast Cancer
Susan G. Komen for the Cure Release: 23rd Annual Komen Pittsburgh Race For The Cure 5K Winners Announced
Susan G. Komen for the Cure Brinker Awardees For Scientific Distinction Deliver Lectures; Honored Today At San Antonio Breast Cancer Symposium
Susan G. Komen for the Cure And Northern Arizona (Komen CAN AZ) Selects And Retains Ideas Collide To Combat Breast Cancer
Susan G. Komen for the Cure Honored for $20 Million in Research Investments to Dana-Farber Cancer Institute
Susan G. Komen for the Cure Release: American and Israeli Researchers Named 2012 Brinker Award Winners for Scientific Distinction